Kintara Therapeutics Inc (NASDAQ:KTRA) currently has a daily average trading volume of 2.86M but it saw 1427052 shares traded in last market. With a market cap of 9.81M USD, the company’s current market price of $0.18 came falling about -5.22 while comparing to the previous closing price of $0.19. In past 52 weeks, the stock remained buoying in the range of price level as high as $4.59 and as low as $0.08. In the recent trading on the day, stock has struck highest price mark of $0.172 while lowest mark touched by it was $0.1836.
Taking a look at 20-day trading activity of Kintara Therapeutics Inc (KTRA) gives us an average price of $0.1831, while its current price level is -96.16% below from 52-week high level whereas it is 117.53% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $0.1880 while that of 200 days or SMA-200 reads an average of $0.1702. A closer look into the stock’s movement over the week reveals that its volatility is standing at 9.55% during that period while stretching the period over a month that increases to 10.69%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 45.71 which implies that the stock is in neutral territory.
Over the week, KTRA’s stock price is moving -5.62% down while it is 1.91% when we observe its performance for the past one month. Year-to-date it is 3.89% up and over the past year, the stock is showing a downside performance of -94.18%.
The latest quarterly earnings report issued by the company reported quarterly earnings per share (EPS) of -1.94 beaten by the consensus estimate of -0.19 for the same. The company is expected to be releasing its next quarterly report in November, for which analysts forecasted an EPS of 0 while estimate for next year EPS is 0.
Currently, Kintara Therapeutics Inc’s total number of outstanding shares is 55.66M. Company’s return on investment (ROI) stands at -226.27% and return on equity (ROE) at -370.77%. Stock’s beta reads 0.80. Its return on asset (ROA) is -163.44% on average.
